Select Medical Holdings Corporation (SEM) — Fair Value Analysis
Base-case fair value (P50): $19.82 · Current price: $16.51 · Verdict: Undervalued
The Verdict on SEM
SELECT MEDICAL HOLDINGS CORP (SEM) appears fairly valued based on our latest Monte Carlo simulations. The simulations indicate a median fair value (P50) of $19.82, representing a +20.0% potential upside from the current price of $16.51. While there is an implied positive return to the P50, this falls within a range that suggests the market is largely pricing SEM appropriately given its current fundamentals and future outlook. Our analysis, which models thousands of forward-looking scenarios, points to a balanced risk/reward profile at the $16.51 level, aligning with the "Fairly Valued" verdict.
How SEM stacks up against peers
Despite the "Fairly Valued" verdict, SEM's operational and financial health is categorized as "weak" when compared to its sector peers. This weak quality tier suggests that while the stock is not significantly over or undervalued based on our P50 fair value of $19.82 against $16.51, investors should be mindful of the underlying operational challenges. The implied +20.0% to the P50 median should be viewed in context of this fundamental quality, indicating that achieving even this modest upside may depend on improvements in its core operational and financial metrics relative to competitors.
What this means for investors
For investors considering SELECT MEDICAL HOLDINGS CORP, the current assessment indicates SEM is fairly valued. The gap between the current trading price of $16.51 and the median fair value of $19.82 suggests that significant mispricing is not presently observed. While there's a +20.0% implied upside, this is consistent with a stock that the market has largely priced efficiently. FairCurve's Monte Carlo analysis provides this P50 as a central estimate, but a wider distribution of potential outcomes exists. To understand the full range of bear and bull case scenarios and track SEM's fair value as new fundamentals are released, sign up for a free FairCurve account today.
Frequently Asked Questions
Is SEM overvalued or undervalued right now?
Based on our Monte Carlo simulations, SEM is considered fairly valued. The median fair value (P50) of $19.82 is close to the current price of $16.51, indicating limited mispricing.
What is the bear case and bull case for SEM?
The full Monte Carlo distribution, which includes specific bear (P10) and bull (P90) target prices and the probability of upside, is available with a free FairCurve account. These detailed scenarios provide a comprehensive view of SEM's potential price movements.
How does FairCurve calculate SEM's fair value?
FairCurve calculates SEM's fair value by running Monte Carlo simulations over thousands of forward-looking scenarios. This robust modeling approach accounts for various market and company-specific factors to derive a probabilistic fair value range.
How can I track SEM's fair value as it changes?
You can easily track SEM's fair value by adding it to a free FairCurve watchlist. This provides daily fair value updates and instant re-valuation whenever new earnings reports or significant fundamental data are released.